Glimitip-M 1 Forte Tablet SR
Manufacturer
Zodley Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (000mg)
Key Information
Short Description
Glimitip-M 1 Forte Tablet SR is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Dosage Form
Tablet SR
Introduction
Glimitip-M 1 Forte Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimitip-M 1 Forte Tablet SR is to be taken with food.
Safety Information
Side Effects
No common side effects listed.
Alcohol Warning
It is unsafe to consume alcohol with Glimitip-M 1 Forte Tablet SR.
Breastfeeding Warning
Glimitip-M 1 Forte Tablet SR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy Warning
Glimitip-M 1 Forte Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Glimitip-M 1 Forte Tablet SR is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
Quick Tips
You should continue to exercise regularly eat a healthy diet and take your other diabetes medicines along with Glimitip-M 1 Forte Tablet SR. Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting, and stomach pain as Glimitip-M 1 Forte Tablet SR may cause a rare but serious condition called lactic acidosis, which is an excess of lactic acid in the blood.
Related Medicines
Gepride M-1 Forte Tablet
Maxformin Fort G 1mg/1000mg Tablet SR
Drmet Forte G1 Tablet SR
GM SR1 Forte Tablet
Dartmet-G1 Forte Tablet SR
Glycinova G1 Forte Tablet SR
Gletan M Forte 1mg/1000mg Tablet SR
Glynamic M 1 Forte Tablet SR
Acmeglim-M1 Forte Tablet SR
Sugargic MF Forte 1mg/1000mg Tablet SR
Frequently asked questions
What are the recommended storage conditions for Glimitip-M 1 Forte Tablet SR?
Store this medicine in its original container or package, tightly closed. Follow the instructions on the label or packaging for proper storage guidance. Do not consume any unused medication and ensure it is inaccessible to pets, children, and other individuals.
Can the use of Glimitip-M 1 Forte Tablet SR lead to lactic acidosis?
Yes, Glimitip-M 1 Forte Tablet SR can increase the risk of lactic acidosis. This condition arises from an excess build-up of lactic acid in the blood. It is also known as MALA (Metformin-associated lactic acidosis) and it is a rare side effect associated with metformin use. Patients with pre-existing kidney conditions, advanced age, or those consuming large amounts of alcohol are particularly susceptible to this risk. Symptoms may include muscle pain, weakness, dizziness, fatigue, cold sensations in extremities, breathing difficulties, nausea, vomiting, stomach discomfort, or slow heart rate. If you experience these symptoms, discontinue Glimitip-M 1 Forte Tablet SR and consult your healthcare provider immediately.
What is Glimitip-M 1 Forte Tablet SR?
Glimitip-M 1 Forte Tablet SR combines two medicines: Glimepiride and Metformin. It is prescribed for type 2 diabetes mellitus (DM) treatment in adults. The combination enhances blood glucose control through diet and exercise. Glimepiride stimulates insulin release from the pancreas, while Metformin reduces glucose production from the liver and improves insulin sensitivity. This combination is not suitable for type 1 DM.
What are the possible side effects of Glimitip-M 1 Forte Tablet SR?
Glimitip-M 1 Forte Tablet SR may cause common side effects like hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, and headache. Long-term use can also lead to rare side effects such as lactic acidosis. Additionally, it can result in Vitamin B12 deficiency with long-term usage.
Can the use of Glimitip-M 1 Forte Tablet SR cause Vitamin B12 deficiency?
Yes, prolonged use of Glimitip-M 1 Forte Tablet SR can lead to Vitamin B12 deficiency. This occurs due to its interference with Vitamin B12 absorption in the stomach. If left untreated, it can result in anemia and nerve problems, including tingling sensations in hands and feet, weakness, urinary disorders, cognitive changes, and difficulty maintaining balance (ataxia). To mitigate this risk, consider supplementing with Vitamin B12 from external sources at least once every year.
Can the use of Glimitip-M 1 Forte Tablet SR lead to hypoglycemia?
Yes, Glimitip-M 1 Forte Tablet SR can cause hypoglycemia (low blood sugar level). This may include symptoms like nausea, headache, irritability, hunger, sweating, dizziness, a fast heart rate, and feelings of anxiety or shakiness. The occurrence is more likely when skipping meals, drinking alcohol, exercising excessively, or taking other antidiabetic medications alongside it. Consistent monitoring of blood glucose levels is crucial.
Is it safe to take alcohol while I am also taking Glimitip-M 1 Forte Tablet SR?
No, consuming alcohol with Glimitip-M 1 Forte Tablet SR is not recommended. This combination can lower blood sugar levels and increase the risk of hypoglycemia. It also raises the likelihood of lactic acidosis.
